Catestatin vs Relaxin-2 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Catestatin is a 21-amino acid peptide derived from the chromogranin A (CgA) protein, specifically cleaved from the region spanning residues 352-372. It was identified as an endogenous inhibitor of catecholamine secretion, acting as a non-competitive antagonist at nicotinic acetyl...
Calculate Catestatin dose →Relaxin-2 (H2 Relaxin) is an endogenous peptide hormone of the insulin superfamily, best known for its roles in pregnancy physiology including cervical ripening, uterine quiescence, and connective tissue remodeling. Beyond reproduction, relaxin-2 is a systemic anti-fibrotic and v...
Calculate Relaxin-2 dose →| Parameter | Catestatin | Relaxin-2 |
|---|---|---|
| Category | Cardiovascular Peptide | Cardiovascular Peptide |
| Research | Preclinical / Early Human | Clinical |
| Half-Life | ~15-30 minutes (IV) | 10-15 min (plasma) |
| Typical Dose | 0.3-3 nmol/kg (animal studies) | 30-300 mcg/kg/day (IV) |
| Frequency | Acute dosing in research | Continuous 48-hour infusion (trials) |
| Route | IV (research); intranasal under study | Intravenous (infusion) |
| FDA Status | Research compound | Not approved (Phase III completed) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.